Why the study?
Is slow coronary flow associated with impaired endothelial function and plasma lipid disturbances?
Case-Control (n=77)
Is slow coronary flow associated with impaired endothelial function and plasma lipid disturbances?
Slow coronary flow is associated with impaired endothelial function, which appears to be driven by plasma lipid disturbances, particularly low HDL-C and high triglycerides.
Slow coronary flow links to endothelial dysfunction via low HDL-C; hypothesis-generating and should not yet change practice.
Previous studies have suggested that microcirculatory abnormalities cause slow coronary flow (SCF). However, the underlying mechanism of this phenomenon has not yet been well documented. Therefore, the aim of this study was to determine the role of plasma lipid disturbances in pathogenesis of slow coronary flow (SCF). Forty patients with SCF (group I) and 37 subjects with normal coronary arteries (group II) were included in the study. In each subject plasma lipid concentrations (total cholesterol [TC], low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglyceride [TG]) and brachial artery flow-mediated dilatation (FMD) and nitroglycerin (NTG)-induced dilatation were measured. Total cholesterol level was found to be similar in the 2 groups. In group I, HDL-C level was lower than in group II (34 +/-3 vs 40 +/-4 mg/dL, p=0.0001). In group I, TG level was higher than in group II (213 +/-29 vs 198 +/-24 mg/dL p=0.002). In group I, FMD was smaller than that of group II (3.48 +/-3.1% vs 10.4 +/-5.6%, p=0.0001). The percent NTG-induced dilatation was not different between the groups (15.5 +/-5.3% vs 17.3 +/-6.9%, p=0.27). On regression analysis; there was a significant relationship between percent of FMD and HDL-C (r =0.65, p=0.0001). When the 2 groups were analyzed separately, HDL-C was still related to percent of FMD in both groups (r =0.47 p=0.002 and r =0.45 p=0.005, respectively). Multivariate regression analysis showed that only plasma HDL-C was independently related to FMD (F=7.5 p=0.0001). In patients with SCF, reduced flow-mediated dilatation was detected and was found to be associated with plasma lipid disturbances, principally low HDL and high TG levels.
No takes yet. Share an insight, caveat, or question.
Sezgin et al. (2006) conducted a case-control in Slow coronary flow (n=77). Slow coronary flow vs. Normal coronary arteries was evaluated on Brachial artery flow-mediated dilatation (FMD) (p=0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: